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Book Reviews
EAnro'-- Aspects of Cacer
Edited by K. Horwitz, Bethesda: The Endocrine Society
Press, 1993, 256 pp.
This monograph is the first in a series from the Endocrine
Society. Each monograph will include a number of articles
recently published in Endocrine Reviews and focus on a par-
ticular topic. These artiles have all been peer revied and,
as a clever addition, the authors have prepared addenda that
update the articles which appeared originally between 1990
and 1992.
Of the ten chapters in Endorn Aspects of Cancer, the
first six address issues dealing with hormones and breast
cancer. Santen et al. provide a comprehensive summary of
the various modalities used in the endocrine treatment of
breast cancer, Jordan and Murphy focus on anti-oestrogens
and their anti-tumour properties, and Li and Li review the
carcinogenic pro of oestrogens. The next two chapters
address the role of progesterone in cell proliferation (Clarke
and Sutherland) and the potential use of progesterone
antagonists in breast cancer (Horwitz). FinaLy, Klijn et al.
discuss the role of growth factors and their receptors in
breast cancer growth and prognosis with parficular emphasis
on epidermal growth factor.
The emnaining chapters discuss the role of hormones in
ovarian cancer (Rao et al.), dopamine agonists and pituitary
tumours (Bevan et al.), somatostatin and its analogues in the
diagnosis and treatment of a variety of malignances
(Lamberts et al.) and the cellular sources and biological
functions of cytokines (Kurzrock et al.).
Overall these ten chapters are high-quality critical, in-depth
state-of-the-art reviews. The book is well produced and
reasonably priced. My only quibble is with the content mix.
The six chapters on breast cancer fit together beaufifully, but
the remainder are more like four isolated additions.
Clinicians and probably scientists interested in dopamine
agonists and pituitary tumours are unlikely to be equally
interest in breast or ovarian cncer and vice versa. It might
have been better to have concentrated on breast cancer and
produced a smaller monograph entitled 'Endocrine Aspects
of Breast Cancer'.
S.M. Shalet
Cardiac Toxkity after Treatmet for C Ca r
Edited by J.T. Bricker, D.M. Green & GJ. D'Angio, New
York: Wiley-Liss, 1993, 133 pp.
As the treatment of children with cancer has improved,
concern about possible late effects has also increased. Over
half the children diagnosed with cancer will now survive
more than 5 years, and one important potential cause of late
excess mortality among these survivors is treatment-related
cardiac damage. The book contains invited presentations
given at the Second International Conference on the Long
Term Complications of Treatment of Children and
Adolescents with Cancer, which was held in Buffalo, New
York, in 1992. These presentations mainly focus on the two
most common agents to cause cardiac damage: radiation
therapy and anthracycline chemotherapy. In the introductory
chapter, Bricker stresses the problem of 'judiciously
navigating the-misty narrow channel between cardiac toxicity
and inappropriate limitations of treatment'. He maintains
that cardiac toxicity should be looked at as a continuous, not
a categorical, variable and that our aim should be to attempt
to preserve cardiac reserve rather than just prevent cardiac
damage. He stresses the number of variables that are con-
cerned in the development of anthracycline cardiac toxcity.
Some are well known, such as dose, age of the patient,
gender, coexisting mediastinal irradiation and ventricular
function before drug treatment. Others are less well recog-
nised, such as individual variations in myocardial activity of
various enzymes such as catalase, superoxide dismutase and
glutathione peroxidase. Previously unrecognised problems,
such as pretreatment iron status, selenium deficiency and
subclinical episodes of viral myocarditis, may also add to the
risk. He stresses that an optimal monitoring strategy has not
yet been found, and talks about the desirability ofdeveloping
load-free ventricular function testing, to overcome the prob-
klms associated with conventional tests such as M-mode
echocardiography, shortening fraction, MUGA scans, ECG
and stress velocity index.
Subsequent chapters in the book discuss the pathology of
radiation and anthracyclne-induced heart disease. Fajardo
concludes that radiation should not be viewed an an indepen-
dent cause ofcoronary artery disease, but as a co-factor with
the agents already known to be associated with this disease,
sine there is no difference in the pathology ofarterial lesions
caused by radiation and those produced by spontaneous
atherosclerosis. Adriamycin does aggravate radiation injury
through a final common end point of diffuse myocrdial
fibrosis, but, whereas for radiation this fibrosis is produced
by endotheial damage, for adriamycin there is direct toxic
effect on myocytes which are then replaced by fibrotic tissue.
The changes produced by adriamycin have been elucidated
by endomyocardial biopsy, which has made it possible to
detect early changes.
After papers disussing the pathology and pathophysiology
of anthracycline cardiac toxicity, the epidemiology of
radiation-related heart disease based on data from Stanford
University is discussed by Hancock and Donaldson, who
have identified 12 heart disease deaths in their group of 635
children and adolescents treated.
The second part of the book is devoted to papers on ways
of monitoring anthracycie therapy in the short and long
term, with regard to the factors summarised by Bricker in his
introduction. Ewer and Benjamin discuss possible ways of
preventing cardiac dam by modifying the way the drug is
given, and Berg and collagues discuss the use of cardiac
protectant agents such as ICRF 187 in modifying the toxicity
of adriamycin.
The final chapter addresses the role of genetic counselling
and the ways in which progress i genetics may make it
possible to identify individuals with significntly icreased
risks of developing late complications of cancer treatment.
The papers are clearly and coherently written and provide
an excellent overview of the subject of cardiac toxicity. It is
an important summary of the current situation both for
clinicians caring for children receiving cardiotoxic therapy
and for those concered with developing new strategies to
minimise problems in the future.
A. Barrett
1e a & Ly_phoma Reviews 2
Edited by A. Polliack, Chur, Switzerland: Harwood
Academic Publishers, 1993, 297pp. £48.00.
This book represents the second in a series of books, the
contents of which have been derived from review articles
published in the journal Leukemia and Lymphoma. This
relatively new journal has rapidly become established as an
important vehicle for publications in haematological onco-
logy. The authors have gathered reviews from volumes 5, 657S BOOK REVIEWS
and 7 of this journal under one cover and under three
general aings of leukaemia, biology and lymphoma. Their
reviews cover a broad spectrum ofaspects ofthese dis in
considerable detail.
On the whole, the individual reviews are authoritative and
clearly written and the list of contributors is impressive. A
criticism of the way in which the book is structured is the
fact that it has been done by disease rather than by the
subject matter of the reviews. For example, there are
several excellent review articks on various aspects of cell
cycle kinetics and cytogenetics and their relationship to out-
come in leukaemia and lymphoma. These various reviews
could have been more sensibly grouped together. The chapter
by Boklhari et al. on cell cyce parameters as predictors of
prognosis in AML demonstrates the correlation of cell ccle
kinetics with outcome, and similar subjects are covered in the
chapter by Tusenius et al. in non-Hodgkin's lymphoma and
also in the chapter on proliferating cell nuclear antigen
(PCNA) by Keim and Hanash. This last chapter proviles an
exceent prescripon of PCNA backed up by a description
of its putative function as a stabiliwr of DNA polymerase.
The changes in the nuclear distribution of PCNA in the cell
cycle are also ckarly described and interesting data are pre-
sented on the relationship between PCNA expression and
clinical parameters such as the incidence of relapse in
patients with ANLLI.
Tusenius et al. review the role of various proliferation
indic iling assesment of mitotic index, transferrin
receptor, the Ki-67 antigen and nucleolar organiser regions.
The chapter descibes wel the potential limitations of this
kind of approach, although unforttely appears too arly
to include recent data from the South-West Oncology Group
prospective study idicating the independent prognostic value
of Ki-67 expression in aggressive lymphoma.
The various chapters on cytogenetic abnormalities and on
their molcular counterparts are also individually ckar but
could have been more sensibly grouped into one section of
the book. The volume also includes a number of clnical
papers of interest.
Ljungman et al. provide an overview of the role of bone
marrow tranWlantation in acute non-lymphoblastic leu-
kaemi
The article is cearly written and well balanc, emphasis-
ing the need for prospective clnical studies to assess its true
value and emphasising the importance of all unrelated donor
transplants being registered.
Johnson and Rohatiner's chapter on the role of high-dose
therapy in folliular lymphoma gives a good overview of
current experience, although it fails to emphasis that com-
parisons between various transplant and non-tansplant
series in this disease are etremely difficult because of incon-
itencies in histological interpretation of the subtypes of
folwular lymphoma. Furthermore, the chapter fails to
emphasise the need for prospective randomised studies in this
dsease.
Other chapters include descriptions of rare clinical entities
in ing splenk lymphoma with villous lymphocytes, mas-
tocytosis and coexent non-Hodgkin's lymphoma and
myelopreliferative disorders, sinus histiocytosis and post-
tansplant lymphoma. Again, all of these provide excellent
reviews by recognised experts.
OveralL this volume provides an interesting collection of
review article on a somewhat diverse subject matter in the
field of leukaemia and lymphoma. Since the articls are
derived from reviews in ajournal they inevitably flkct issues
regrded as important at the time ofwriting and therefore do
not easily fall into neat groupings for a book. Because of this
it is difficult to detemine exactly who is likcely to be interest-
ed in having this kid of volume other than those people
who are liely to read the journal in any case. Nevertheless,
the quality of the authorship and of the articles is on the
whole excllent, and for this reason alone it should be recom-
mended.
J.W. Sweetenham
Figra~ (r_metHHG-CSF) in C1ncal Pactice. Ba.c and
C~aI Oacology Series/5
Edited by G. Morstyn & T.M. Dexter, New York: Marcel
Dekier Inc., 1993, 368pp. $125.00.
Filgrastim in Clinical Practice is the fifth volume in the Basic
and Clinical Oncology series edited by Bruce Cheson.
Granulocyte colony-stimulating factor (G-CSF) was the first
human haemopoietic growth factor to be introduced into
clinical practice; 'Filgastim' is its generic name. Short
chapters on the biology, biochemistry and pharmacology are
included. Other chapters cover the role of G-CSF in treating
patients with chronic neutropenia and in ameliorating
neutropenia with reduction in the incidence of infection fol-
lowing intensive chemotherapy. The use of G-CSF in
mobilisng peripheal blood progenitor cells for haemopoietic
rescue following myeloablative chemotherapy is the subject
of a further chapter, and the final pages cover economic,
social and practical aspects of adminitation.
The chapters are relatively short and do not provide an
extensive review of the literature, and inevitably in a book of
this nature the assessment ofpublished work is 2-3 years out
of date. However, the book does provide the clinician with
important basic information on the use of G-CSF in the
clinic. Although one ofthe editors and several of the authors
are Amgen Inc. staff, the book does provide a reasonably
alanced view of the clinical role of G-CSF. However, any
economic advantage is eroding and its exact role in cinical
practice is changing with time. This book does provide the
clinician with a useful introduction to the clnical uses of
G-CSF, but in view of the expense of the agent the reader
should be advised that specific indications for its use require
continuing rea t in the light of new research defining
the role of intensive chemotherapy, growth factors and
haemopoietic stem cel rescue.
D. Crowther
D;isg.~ of Coloectal so Ovarian Card.omaA t
of I Tec,ogy
Edited by R.T. Maguire & D. Van Nostrand, New York:
Marcel Dekker, 1992, 260pp.
This book is one of a series on targeted diagnosis and
therapy which focuses on individual products or strategy for
targeted therapy. The generation and characterisation of the
monoclonal antibody B72.3 as well as the extensive pre-
clinical and clinical data are reviewed in some detail. This is
one of the most widely studied anti-tumour monoclonal
antibodies and binds a high molcular weight mucin-like
glycoprotein frequently expressed by common epithelium-
derived malignanies such as those of the colon, ovary, lung
and breast. It was generated in 1981 by conventional hy-
bridoma technology utilising the membrane fraction of cells
derived from breast cancer metastases as the immunogen.
Since then a vast number ofpreclinical and clinical data have
been generated and the antibody has been modified by ug
the techniques of antibody engineering.
The initial chapter is an excellent historical review of
radioimmunoimaging with good sections on the relative
merits ofdifferent labelling agents and some discussion ofthe
future prospects for this technology. The chapter on the
initial generation, characterisation and preclnical testing is
authoritative and indicates the typical development of
antibodies from isolation to clinical application. The major
portion of the book concentrates on the use of B72.3 in
colorectal cancer imaging, and these chapters are likewise
valuable, although some of the data are repetitive, with
chapters describing different groups, experience of imaging
with this antibody. Although a straightforward overview
might have been more helful, this is, to some extent, pro-
vided by a chapter on a multicentre trial. Overall, the book
suggests that radioimmunoimaging with this antibody has
sensitivity and specificity comparable to conventional